I have a major beef with the Cancer Society but am
Post# of 72440
The money can't all go to not-for-profits as the bulk seems to go to Hospitals doing research.
Bottom line is Kevetrin should be high in the sights of Cancer Society decision makers and, if it isn't, then they aren't worth squat in knowing their business. And if they know about Kevetrin, why haven't they thrown some money our way so we could proceed on the pill and get it into a quick trial to show it is as safe as the infusion method and doesn't cause systemic buildup and thus allow it to quickly get into numerous trials with complementary other cancer treatments?